Jiangsu Nhwa Pharmaceutical Co., LTD approved cash dividend of CNY 2.00000000 per ten shares (tax included) for the year 2021, at its AGM held on April 29, 2022.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
24.69 CNY | -0.92% | -2.22% | -8.96% |
19/04 | Jiangsu Nhwa Pharmaceutical Co., LTD Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
03/04 | Nhwa Pharma Gets Nod to Test NH103 Oxalate Tablets | MT |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-8.96% | 3.44B | |
+31.64% | 588B | |
-3.42% | 364B | |
+18.02% | 326B | |
+4.27% | 285B | |
+15.45% | 239B | |
+10.06% | 210B | |
-7.32% | 200B | |
+8.12% | 167B | |
-1.42% | 161B |
- Stock Market
- Equities
- 002262 Stock
- News Jiangsu Nhwa Pharmaceutical Co., LTD
- Jiangsu Nhwa Pharmaceutical Co., Ltd Approves Cash Dividend for the Year 2021